Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) — Cash Flow-to-Debt Ratio
Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2023, meaning its operating cash flow of ILA-4.35 Million could theoretically repay 0% of its total liabilities (ILA43.77 Million) in one year. See Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tikun Olam Cannbit Pharmaceuticals Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Tikun Olam Cannbit Pharmaceuticals Ltd across 8 annual periods. Also explore TKUN net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
Year-by-year debt coverage analysis for Tikun Olam Cannbit Pharmaceuticals Ltd. For market capitalisation and broader financial context, see Tikun Olam Cannbit Pharmaceuticals Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (ILA) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.13x | ILA-3.77 Million | ILA29.36 Million | ▼ -85.0% |
| 2023 | -0.07x | ILA-3.02 Million | ILA43.53 Million | ▲ +84.8% |
| 2022 | -0.46x | ILA-18.22 Million | ILA39.90 Million | ▲ +9.5% |
| 2021 | -0.50x | ILA-23.17 Million | ILA45.96 Million | ▼ -21.5% |
| 2020 | -0.41x | ILA-24.38 Million | ILA58.75 Million | ▼ -586.9% |
| 2019 | -0.06x | ILA-3.36 Million | ILA55.56 Million | ▲ +75.9% |
| 2018 | -0.25x | ILA-1.76 Million | ILA7.01 Million | ▼ -44.0% |
| 2017 | -0.17x | ILA-106.29K | ILA610.00K | — |